國立高雄大學圖資館 |

Precision approaches to heterogeneity in asthma

Record Type:	Electronic resources : Monograph/item
Title/Author:	Precision approaches to heterogeneity in asthmaedited by Allan R. Brasier, Nizar N. Jarjour.
other author:	Brasier, Allan R.
Published:	Cham :Springer International Publishing :2023.
Description:	x, 418 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	Asthma.
Online resource:	https://doi.org/10.1007/978-3-031-32259-4
ISBN:	9783031322594$q(electronic bk.)

Precision approaches to heterogeneity in asthma
Precision approaches to heterogeneity in asthma[electronic resource] /edited by Allan R. Brasier, Nizar N. Jarjour. - Cham :Springer International Publishing :2023. - x, 418 p. :ill., digital ;24 cm. - Advances in experimental medicine and biology,v. 14262214-8019 ;. - Advances in experimental medicine and biology ;946..

Introduction Part I -- The spectrum of asthma epidemiology -- Disease prevalence and burden -- Climate considerations in asthma and impacts of climate change -- Asthma across the ages: children, women, and the elderly -- Asthma as a systemic disease: neurologic, cardiac and metabolic changes in asthma -- Social determinants of health in asthma -- Part II. Mechanistic heterogeneity in asthma, -Phenotypes and endotypes -- Heterogeneity of treatment response to asthma (including mild-moderate asthma) -- Regional airway involvement: Imaging heterogeneity in ventilation, mucus and remodeling -- Biobehavioral determinants of asthma, including CNS influences and dietary/nutrition -- Integrative/ Systems levels studies -- Part III. Severe and difficult to treat asthma endotypes -- Definition, phenotyping of severe asthma, including cluster analysis -- Asthma exacerbations: patient features and potential long-term implications -- Innate inflammation driven remodeling -- Adaptive immunity and remodeling -- Part IV. Influence of heterogeneity on approaches to management -- Approaches to management of asthma -- Guidelines for stepped care and self-monitoring -- Global considerations in asthma treatment - management in low resource settings -- Update on biomarker-driven approaches and precision medicine- adaptive clinical trials e.g., PRECISE -- Conclusion and future directions.

Asthma has been challenging to treat due to its heterogeneous onset, environmental triggers, severity, and treatment response. To embrace the rapid advances in this field, Precision Approaches to Heterogeneity in Asthma follows its highly successful predecessor, Heterogeneity in Asthma. In this new volume, noted authorities Allan Brasier and Nizar Jarjour and a cadre of leaders in the field incorporate new work advancing our understanding of phenotypes (endotypes) of disease, regional variations in ventilation, systems approach to analyzing the findings from studies of inducible phenotypes, and emerging results of biomarker-informed clinical trials. This work will facilitate our current understanding of the spectrum of disease etiology, prognosis, and the likelihood of responding to the range of available therapeutic interventions.

ISBN: 9783031322594$q(electronic bk.)

Standard No.: 10.1007/978-3-031-32259-4doiSubjects--Topical Terms:

496958
Asthma.

LC Class. No.: RC591

Dewey Class. No.: 616.238

Precision approaches to heterogeneity in asthma
LDR:03305nmm a2200337 a 4500 001 648185
003 DE-He213
005 20230718203047.0
006 m d
007 cr nn 008maaau
008 240116s2023 sz s 0 eng d
020 $a 9783031322594$q(electronic bk.)
020 $a 9783031322587$q(paper)
024 7 $a 10.1007/978-3-031-32259-4 $2 doi
035 $a 978-3-031-32259-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC591
072 7 $a MJL $2 bicssc
072 7 $a MED079000 $2 bisacsh
072 7 $a MJL $2 thema
082 0 4 $a 616.238 $2 23
090 $a RC591 $b .P923 2023
245 0 0 $a Precision approaches to heterogeneity in asthma $h [electronic resource] / $c edited by Allan R. Brasier, Nizar N. Jarjour.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2023.
300 $a x, 418 p. : $b ill., digital ; $c 24 cm.
490 1 $a Advances in experimental medicine and biology, $x 2214-8019 ; $v v. 1426
505 0 $a Introduction Part I -- The spectrum of asthma epidemiology -- Disease prevalence and burden -- Climate considerations in asthma and impacts of climate change -- Asthma across the ages: children, women, and the elderly -- Asthma as a systemic disease: neurologic, cardiac and metabolic changes in asthma -- Social determinants of health in asthma -- Part II. Mechanistic heterogeneity in asthma, -Phenotypes and endotypes -- Heterogeneity of treatment response to asthma (including mild-moderate asthma) -- Regional airway involvement: Imaging heterogeneity in ventilation, mucus and remodeling -- Biobehavioral determinants of asthma, including CNS influences and dietary/nutrition -- Integrative/ Systems levels studies -- Part III. Severe and difficult to treat asthma endotypes -- Definition, phenotyping of severe asthma, including cluster analysis -- Asthma exacerbations: patient features and potential long-term implications -- Innate inflammation driven remodeling -- Adaptive immunity and remodeling -- Part IV. Influence of heterogeneity on approaches to management -- Approaches to management of asthma -- Guidelines for stepped care and self-monitoring -- Global considerations in asthma treatment - management in low resource settings -- Update on biomarker-driven approaches and precision medicine- adaptive clinical trials e.g., PRECISE -- Conclusion and future directions.
520 $a Asthma has been challenging to treat due to its heterogeneous onset, environmental triggers, severity, and treatment response. To embrace the rapid advances in this field, Precision Approaches to Heterogeneity in Asthma follows its highly successful predecessor, Heterogeneity in Asthma. In this new volume, noted authorities Allan Brasier and Nizar Jarjour and a cadre of leaders in the field incorporate new work advancing our understanding of phenotypes (endotypes) of disease, regional variations in ventilation, systems approach to analyzing the findings from studies of inducible phenotypes, and emerging results of biomarker-informed clinical trials. This work will facilitate our current understanding of the spectrum of disease etiology, prognosis, and the likelihood of responding to the range of available therapeutic interventions.
650 0 $a Asthma. $3 496958
650 0 $a Asthma $x Genetic aspects. $3 957889
650 0 $a Asthma $x Etiology. $3 326472
650 1 4 $a Pneumology. $3 925412
650 2 4 $a Immunology. $3 189152
650 2 4 $a Immunogenetics. $3 246110
650 2 4 $a Human Physiology. $3 274509
700 1 $a Brasier, Allan R. $3 587615
700 1 $a Jarjour, Nizar N. $3 957888
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
830 0 $a Advances in experimental medicine and biology ; $v 946. $3 557559
856 4 0 $u https://doi.org/10.1007/978-3-031-32259-4
950 $a Biomedical and Life Sciences (SpringerNature-11642)